Caragh Murphy

Title: Caragh Murphy: Innovator in Gastroretentive Pharmaceutical Dosage Forms

Introduction: Caragh Murphy is an accomplished inventor based in Kensington, South Africa. With her innovative approach in the pharmaceutical field, she has made significant strides with her patented invention related to gastroretentive dosage forms. Her work contributes to advancements in drug delivery systems, enhancing the effectiveness of pharmaceutical treatments.

Latest Patents: Caragh holds a patent for a "Multi-unit gastroretentive pharmaceutical dosage form comprising microparticles." This invention revolves around an orally administrable dosage form that contains at least one pharmaceutically active ingredient and one polymeric adjuvant. The polymeric adjuvant functions to retain the dosage form in a specific section of the gastrointestinal tract for a prolonged duration. This ensures that the active ingredient can be released and absorbed effectively. Additionally, the dosage form is designed to deliver multiple active ingredients to different regions in the gastrointestinal tract, optimizing therapeutic outcomes.

Career Highlights: Caragh Murphy is affiliated with the University of the Witwatersrand in Johannesburg, where she is engaged in groundbreaking research in pharmaceutical sciences. Her role in the academic institution allows her to combine her inventive prowess with her passion for education and research, fostering innovation in the field.

Collaborations: Throughout her career, Caragh has collaborated with esteemed colleagues, including Viness Pillay and Yahya Essop Choonara. These partnerships have enabled her to enhance her research and work on projects that push the boundaries of existing pharmaceutical technologies.

Conclusion: Caragh Murphy exemplifies the innovative spirit through her work in the pharmaceutical field. Her patented invention showcases the potential for advancements in dosage forms and highlights the importance of retention in the gastrointestinal tract for efficient drug delivery. With a strong foundation in research and collaboration, Caragh continues to contribute valuable insights and advancements to the world of pharmaceuticals.